GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/IBD/IUS Steroid Failure and Colectomy Risk in Pediatric ASUC: Gastroenterology | August 2026
3

IUS Steroid Failure and Colectomy Risk in Pediatric ASUC: Gastroenterology | August 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated August 1, 2026

Acute severe ulcerative colitis (ASUC) in children requires rapid identification of intravenous corticosteroid failure to avoid delayed rescue therapy and colectomy. Intestinal ultrasound (IUS) offers a noninvasive, repeatable bedside assessment of bowel inflammation. This prospective multicenter study evaluated whether early and serial IUS can predict short-term treatment outcomes in pediatric ASUC.

Why was this study needed?

Around two-thirds of children with ASUC may require escalation beyond intravenous steroids.

Early prediction of steroid failure could accelerate rescue therapy.

Current decisions rely predominantly on clinical scores such as PUCAI.

IUS could provide an objective, radiation-free tool for real-time disease monitoring.

Results:

Among 60 children across 10 European centers, 65% were steroid nonresponders requiring infliximab, while 17% ultimately underwent colectomy.

Early IUS showed that greater colonic wall thickness (CWT), particularly >5 mm in the left lower quadrant, and increased vascularity predicted steroid resistance.

Repeat IUS at days 5–7 further predicted medical treatment failure and colectomy, with persistent CWT and high Milan Ultrasound Scores identifying high-risk patients.

Conversely, improvement in ultrasound parameters was associated with steroid-free remission at 8 weeks.

Clinical Impact:

IUS could become a valuable bedside decision-making tool in pediatric ASUC, complementing PUCAI by objectively assessing bowel inflammation. Early and serial scans may identify steroid nonresponders sooner, allowing timely escalation to infliximab or other rescue therapies while recognizing patients at increased risk of colectomy.

Bottom Line:

Early and serial intestinal ultrasound can predict steroid resistance, medical treatment failure, and colectomy risk in children with acute severe UC. IUS may provide a practical, noninvasive tool for earlier treatment escalation and tighter monitoring of pediatric ASUC.

Related Q&A

04

IUS For Detecting Postoperative Crohn's Disease Recurrence: The Lancet Gastroenterology & Hepatology | July 2026

Introduction: Endoscopic assessment remains the standard for detecting postoperative recurrence after ileocolic resection in Crohn's disease, but it is invasive and resource-intensive. This international multidisciplinary RAND/UCLA consensus developed...

05

Diet and IBD Flares: Gut | July 2026

Introduction: Patients with inflammatory bowel disease (IBD) frequently ask whether diet influences disease relapse, yet high-quality prospective evidence has been scarce. The multicenter PREdiCCt study evaluated the impact...

06

Stopping Thiopurines After Starting Anti-TNF Therapy: CGH | July 2026

Introduction: Combination therapy with anti–tumor necrosis factor (anti-TNF) agents and thiopurines improves treatment efficacy in inflammatory bowel disease (IBD), but long-term thiopurine use raises concerns regarding infection and...

07

Clinical Guideline Update: Management of Ulcerative Colitis in Adults from updated ACG Clinical Guideline: JAMA | July 2026

Introduction: Ulcerative colitis (UC) is a chronic inflammatory disease characterized by relapsing and remitting colonic inflammation. The updated 2025 American College of Gastroenterology (ACG) Guideline emphasizes treat-to-target management,...

08

Alcohol Metabolism Determines IBD Risk: Gut | July 2026

Introduction: The relationship between alcohol consumption and inflammatory bowel disease (IBD) has remained controversial. This large prospective study demonstrates that the effect of alcohol depends on an individual's...

09

Intestinal Ultrasound for Monitoring IBD: JCC | July 2026

Introduction: Endoscopy remains the gold standard for assessing inflammatory bowel disease (IBD) activity but is invasive, costly, and resource-intensive. This real-world study evaluated whether integrating intestinal ultrasound (IUS)...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer